Recombinant ITGAL (Efalizumab Biosimilar) anticorps

N° du produit ABIN7515690

Détail du produit anti-ITGAL (Efalizumab Biosimilar) anticorps

Antigène: ITGAL (Efalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), Immunohistochemistry (IHC)

Fonction: Recombinant mouse monoclonal antibody raised against human CD11a.

Specificité: Binds to human LFA-1.

Réactivité croisée: Humain

Immunogène: Original antibody is raised against Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1, which is expressed on all leukocytes.

Clone: Hu1124

Isotype: IgG2a

Information d'application

Indications d'application: Flow cytometry,Immunohistochemistry,The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur ITGAL (Efalizumab Biosimilar)

Antigène: ITGAL (Efalizumab Biosimilar)

Abstract: ITGAL (Efalizumab Biosimilar) Produits

Synonymes: anticorps CD11A, anticorps LFA-1, anticorps LFA1A, anticorps integrin subunit alpha L, anticorps ITGAL

Classe de substances: Biosimilar

Sujet: Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide)

ID gène: 3683